Pharmaco - Press Releases

Date	Title	Company
14-Sep-2021	Abivax provides an update on the ABX464 clinical data and development strategy in ulcerative colitis	ABIVAX
14-Sep-2021	HUTCHMED Receives Breakthrough Therapy Designation in China for Amdizalisib (HMPL-689) for Treatment of Relapsed or Refractory Follicular Lymphoma	HUTCHMED (China) Limited
14-Sep-2021	Almost 75% of Doctors Say They Have Seen an Increase in Covid-19 in Children, But Only 10% or Less of Children 12+ Are Breakthrough Cases, New Survey Shows	B3C newswire
14-Sep-2021	Two Journal Articles Cite Cleanascite™ in Studies of Lipid Influences in Cell Response Assays	Biotech Support Group
14-Sep-2021	Loughborough MP officially opens former Lighthouse Lab at Charnwood Campus	Dante Labs
14-Sep-2021	Beckley Psytech announces first patient has received low-dose psilocybin in world-first clinical trial for rare headache disorder	Beckley Psytech
14-Sep-2021	ISA Pharmaceuticals Receives Fast Track Designation for Lead Product ISA101b	ISA Pharmaceuticals
14-Sep-2021	Terumo Blood and Cell Technologies announces a new software update for its Finia(R) Fill and Finish System as the cell and gene therapy industry evolves toward automation	Terumo
14-Sep-2021	Once Daily JYSELECA ®▼ (filgotinib) Made Available on the NHS across Scotland for People with Severe Rheumatoid Arthritis	Galapagos UK
14-Sep-2021	EISAI TO JOIN THE GLOBAL EMVIRONMENTAL INITIATIVE “RE100”	EISAI
14-Sep-2021	Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases	Johnson & Johnson
14-Sep-2021	DEFENCE THERAPEUTICS SUCCESS IN TESTING IT'S COVID-19 ACCUVAC-PT001 VACCINE IN A NON-RODENT MODEL	Defence Therapeutics Inc.
14-Sep-2021	APONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and hyperlipidemia	APONTIS PHARMA AG
14-Sep-2021	Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Publish its Financial Results for H1 2021 and Operational Progress	Vivoryon Therapeutics N.V.
13-Sep-2021	IBM Research and Arctoris accelerate closed loop drug discovery with AI and Cloud	Arctoris
13-Sep-2021	Epigenomics AG places maximum number of mandatory convertible bonds with a total volume of EUR 16.5 million	Epigenomics AG
13-Sep-2021	Relief Therapeutics Provides Update on Regulatory Interactions in the United Kingdom and European Union Relating to Lead Drug Candidate, RLF-100 (Aviptadil)	RELIEF THERAPEUTICS Holding AG
10-Sep-2021	Roche signs definitive share purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases	Roche
10-Sep-2021	Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress	Janssen
10-Sep-2021	Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration	Boehringer Ingelheim